Dollar General Corp. (0IC7)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 133.53 |
|---|---|
| 52-week range | 93.52 – 156.25 |
| Return, 1 month / 3 months | +7.4% / +11.0% |
| Return, 1 year / 3 years | +32.2% / +36.2% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 37.0% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 0.45M USD |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dollar General is a discount retailer that runs small neighbourhood stores across the United States, with a focus on rural towns and communities that larger retailers often do not serve. Its shelves carry everyday essentials such as food and snacks, cleaning and household supplies, health and beauty items, and basic apparel and seasonal goods. Customers are mainly value-conscious households doing routine shopping close to home. The company is based in Goodlettsville, Tennessee.
On this site Dollar General Corp. appears as a stock on the London Exchange (UK), code 0IC7, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dollar General Corp. (0IC7) trades on the London Exchange in UK. It last closed at USD 133.53 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,796 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.2% and over the last three months it rose 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.4% | ||
| From 52-week high | -13.2% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.0% | ||
| 6-month return | 7.7% | ||
| 12-month return, skipping the last month | 23.2% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.45M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.6% |
|---|---|
| 1 month | +7.4% |
| 3 months | +11.0% |
| 6 months | +7.7% |
| 1 year | +32.2% |
| 3 years | +36.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 124.77 / 125.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | USD 0.5900 |
| 6 Jul 2026 | USD 0.5900 |
| 2 Apr 2026 | USD 0.5900 |
| 5 Jan 2026 | USD 0.5900 |
| 6 Oct 2025 | USD 0.5900 |
| 7 Jul 2025 | USD 0.5900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.